Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Venus Medtech (Hangzhou) Inc. is set to hold its 2024 Second Class Meeting for holders of unlisted foreign shares on December 5, 2024, in Hangzhou, China. The meeting aims to discuss and approve proposed amendments to the company’s articles of association and Rule 2.07A. Shareholders are encouraged to attend and vote on these significant resolutions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.